One thousand patients with essential thrombocythemia: the Florence-CRIMM experience.

Authors:
Loscocco GG; Gesullo F; Capecchi G; Atanasio A; Maccari C and 3 more

Journal:
Blood Cancer J

Publication Year: 2024

DOI:
10.1038/s41408-023-00968-7

PMCID:
PMC10796728

PMID:
38238287

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: Blood Cancer J

Detailed journal information not available.

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

3/6

50.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Competing interests The authors declare no competing interests."

Funding Disclosure

Evidence found in paper:

"This work has received financial support from Associazione Italiana per la Ricerca sul Cancro (AIRC) 5×1000 call “Metastatic disease: the key unmet need in oncology” to MYNERVA (MYeloid NEoplasms Research Venture AIRC), project #21267; also supported by Ministero della Salute, Rome, Italy [Finalizzata 2018, NET-2018–12365935, Personalized medicine program on myeloid neoplasms: characterization of the patient’s genome for clinical decision making and systematic collection of real-world data to improve quality of health care]."

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025